SCHEMBL9072

SCHEMBL9072

CCOc1ccc(B(O)O)cc1

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 1/20 0.64
CA2 P00918 3/20 0.58
CA1 P00915 2/20 0.58
ENPP2 Q13822 1/20 0.58
LPL P06858 3/20 0.52
LIPG Q9Y5X9 3/20 0.52
TSHR P16473 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
LTA4H P09960 2/20 0.52
PARP10 Q53GL7 1/20 0.48
PRSS1 P07477 1/20 0.48
PRSS2 P07478 1/20 0.48
PRSS3 P35030 1/20 0.48
ADRA2A P08913 2/20 0.47
MAPT P10636 1/20 0.47
NPC1 O15118 1/20 0.46
PLK1 P53350 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3710609 0.94 NQO1 (0.56) NQO1CA2CA1ENPP2LPL
SCHEMBL29955744 0.85 CA2 (0.52) NQO1CA2CA1ENPP2LPL
SCHEMBL257577 0.83 LTA4H (0.55) CA2CA1ENPP2LPLLIPG
SCHEMBL623764 0.83 CA1 (0.57) CA2CA1ENPP2LPLLIPG
SCHEMBL8514 0.82 CA1 (0.52) NQO1CA2CA1ENPP2LPL
SCHEMBL3630920 0.82 CA1 (0.48) NQO1CA2CA1ENPP2LPL
SCHEMBL29953867 0.82 CA1 (0.52) NQO1CA2CA1ENPP2LPL
Morpholine SCHEMBL16244866 0.82 FKBP1A (0.43) NQO1CA2CA1ENPP2LPL
SCHEMBL18245361 0.81 NQO1 (0.70) NQO1CA2CA1TSHRTDP1
1,4-Diethoxybenzene SCHEMBL124015 0.80 NQO1 (1.00) NQO1CA2CA1TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1221 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250194617-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2025-06-19 US claimed
US-20250169514-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2025-05-29 US claimed
CN-119799320-A Organic narrow-band afterglow material based on halation benzene derivative and preparation and application methods thereof 中国科学院上海有机化学研究所 2025-04-11 CN claimed
CN-115959993-B Synthesis method of 2-aryl propionic acid compound 山东中医药大学 2025-01-07 CN claimed
CN-119100758-A Low-heat-conduction multilayer composite magnesia-hercynite brick and preparation method thereof 郑州瑞泰耐火科技有限公司 2024-12-10 CN claimed
CN-118344321-A Gamma-pyrone derivative and synthetic method and application thereof 武汉轻工大学 2024-07-16 CN claimed
CN-113444125-B Phosphoramidite ligand, preparation method thereof and application thereof in asymmetric carbonylation reaction 西北大学 2024-01-26 CN claimed
WO-2024016826-A1 6-POSITION SUBSTITUTED DIHYDROBENZO[E][1,2,3]OXATHIAZINE 2,2-DIOXIDE COMPOUND, PREPARATION THEREFOR, AND USE THEREOF 杭州市第七人民医院 2024-01-25 WO claimed
US-20230380457-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2023-11-30 US claimed
EP-4280882-A2 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. (US) 2023-11-29 EP claimed
WO-2022159439-A2 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. (US) 2022-07-28 WO claimed
US-20220225646-A1 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. 2022-07-21 US claimed
US-20220225647-A1 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. 2022-07-21 US claimed
CN-114478500-A Coumarin two-photon initiator and synthesis method and application thereof 浙江大学 2022-05-13 CN claimed
CN-113444125-A Novel phosphoramidite ligand, preparation method thereof and application thereof in asymmetric carbonylation reaction 西北大学 2021-09-28 CN claimed
CN-108314630-B Oxime ether derivative and preparation method and application thereof 广西民族大学 2020-11-06 CN claimed
US-8361484-B2 Polymer systems for lung volume reduction therapy AERIS THERAPEUTICS, INC. (US) 2013-01-29 US claimed
US-20100040538-A1 Polymer Systems for Lung Volume Reduction Therapy CANADIAN IMPERIAL BANK OF COMMERCE (CA) 2010-02-18 US claimed
EP-2059227-A2 POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY Aeris Therapeutics, Inc. (US) 2009-05-20 EP claimed
WO-2008039827-A2 POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY AERIS THERAPEUTICS, INC. (US) 2008-04-03 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100040538-A1 Polymer Systems for Lung Volume Reduction Therapy GFER, MUC1, CTH NQO1 930/4885CA2 2856/4885CA1 1918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.